127 related articles for article (PubMed ID: 23002033)
1. Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis.
Li B; Cai W; Lv D; Guo X; Zhang J; Wang X; Fang J
J Magn Reson Imaging; 2013 Jan; 37(1):194-200. PubMed ID: 23002033
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
3. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
5. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
[TBL] [Abstract][Full Text] [Related]
6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
7. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
8. [A comparison of magnetic resonance spectroscopy and diffusion weighted imaging for diagnosing prostate cancer].
Peng T; Wu B; Xiao JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):827-31, 842. PubMed ID: 24325122
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
10. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
[TBL] [Abstract][Full Text] [Related]
12. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
13. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted signal models in healthy and cancerous peripheral prostate tissues: comparison of outcomes obtained at different b-values.
Mazzoni LN; Lucarini S; Chiti S; Busoni S; Gori C; Menchi I
J Magn Reson Imaging; 2014 Mar; 39(3):512-8. PubMed ID: 23723087
[TBL] [Abstract][Full Text] [Related]
15. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
Kim JH; Kim JK; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
17. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
18. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
[TBL] [Abstract][Full Text] [Related]
19. Diffusion tensor imaging of prostate at 3.0 Tesla.
Li C; Chen M; Li S; Zhao X; Zhang C; Liu M; Zhou C
Acta Radiol; 2011 Sep; 52(7):813-7. PubMed ID: 21586608
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Dwivedi SN; Hemal AK; Gupta NP
NMR Biomed; 2007 Aug; 20(5):505-11. PubMed ID: 17167820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]